Vol 3 Issue 3

CELL AND GENE THERAPY INSIGHTS

March 2017 Issue

Vol 3 Issue 3

Download PDF

Featuring

Issue Spotlight: Raw Materials for Cell & Gene Therapy: Getting it Right from the Start
Other articles
Webinar

SPOTLIGHT

Raw Materials for Cell & Gene Therapy: Getting it Right from the Start

Innovator Insight

Raw materials for cell & gene therapy: exploring regulatory and supply issues

Raw materials for cell & gene therapy: exploring regulatory and supply issues

Bernd Leistler
10 April 2017
Read
Strategic & practical considerations in raw material selection & sourcing for cell therapies

Strategic & practical considerations in raw material selection & sourcing for cell therapies

David Wellis, Robert Tressler
10 April 2017
Read

Interview

Impact of raw & starting materials on the manufacture and regulation of gene & cell therapies

Impact of raw & starting materials on the manufacture and regulation of gene & cell therapies

Richard Dennett, Valerie Pimpaneau, Francois Gianelli
11 April 2017
Read
Scope and challenges of managing particulates in cell therapy manufacturing

Scope and challenges of managing particulates in cell therapy manufacturing

Jean Stanton
10 April 2017
Read
Commercial considerations for raw materials in the cell and gene therapy industry

Commercial considerations for raw materials in the cell and gene therapy industry

jon rowley
10 April 2017
Read

Journal articles

Research Article

Daidzein analog 2l enhances osteogenic differentiation of BMSCs and ASCs seeded on PLGA scaffolds and heals critical size calvarial defects

Daidzein analog 2l enhances osteogenic differentiation of BMSCs and ASCs seeded on PLGA scaffolds and heals critical size calvarial defects

A Strong, M E Bateman, R B Jones et al.
12 April 2017
Read

Webinars